The impact of bone marrow irradiation dose on acute haematologic toxicity in cervical cancer patients treated with concurrent chemoradiotherapy

Abstract Objective To evaluate the impact of bone marrow (BM) irradiation dose on acute haematologic toxicity (HT) in concurrent chemoradiotherapy for cervical cancer. Methods Sixty-nine patients with cervical cancer treated with curative or postoperative adjuvant therapy received weekly cisplatin c...

Full description

Bibliographic Details
Main Authors: Min Chen, Dajiang Wang, Zhirong Bao, Zongbi Yi, Zijie Mei, Shaoxing Sun, Qingming Xiang, Chunxu Yang, Hui Yang, Hui Qiu, Conghua Xie
Format: Article
Language:English
Published: BMC 2023-04-01
Series:Radiation Oncology
Subjects:
Online Access:https://doi.org/10.1186/s13014-023-02248-x
_version_ 1797849937984094208
author Min Chen
Dajiang Wang
Zhirong Bao
Zongbi Yi
Zijie Mei
Shaoxing Sun
Qingming Xiang
Chunxu Yang
Hui Yang
Hui Qiu
Conghua Xie
author_facet Min Chen
Dajiang Wang
Zhirong Bao
Zongbi Yi
Zijie Mei
Shaoxing Sun
Qingming Xiang
Chunxu Yang
Hui Yang
Hui Qiu
Conghua Xie
author_sort Min Chen
collection DOAJ
description Abstract Objective To evaluate the impact of bone marrow (BM) irradiation dose on acute haematologic toxicity (HT) in concurrent chemoradiotherapy for cervical cancer. Methods Sixty-nine patients with cervical cancer treated with curative or postoperative adjuvant therapy received weekly cisplatin concurrent chemotherapy (CCT) and intensity-modulated radiation therapy (IMRT). The whole pelvic bone marrow (PBM) was delineated and divided into three subsites: ilium (IL), lower pelvis (LP), and lumbosacral spine (LS). Associations between clinical variables, dose volume of BM, including PBM, IL, LP, and LS in the form of x-Vy (volume receiving y Gy for x), and blood cell count nadir were tested using linear regression models. Receiver operating characteristic (ROC) curve analysis was further used to analyse the cutoff values of the variables with p < 0.05 in the multivariate analysis. Results In 69 patients, the haemoglobin nadir was positive correlated with baseline haemoglobin (p < 0.001), negative correlated with relative LP-V10 (p = 0.005), relative LP-V25 (p = 0.002), relative LP-V50 (p = 0.007), relative LP-mean (p = 0.003), absolute LP-V15 (p = 0.049), absolute LP-V25 (p = 0.004) and absolute LP-V30 (p = 0.009). The platelet nadir was positive correlated with baseline platelets (p = 0.048) and negative correlated with relative LP-V40 (p = 0.028), but there was no significant variable in absolute radiation volume by multivariate analysis. No variables related to the neutrophil nadir were found, and the 69 patients were divided into group A (43 cases) receiving 3–4 cycles of CCT and group B (26 cases) receiving 5–6 cycles of CCT. In group A, the relative IL-V15 (p = 0.014), the relative IL-V50 (p = 0.010) and the absolute LP-V50 (p = 0.011) were negative correlated with the neutrophil nadir. No significant variable was found in group B. No significant variables related to the lymphocyte nadir were found, and the neutrophil-to-lymphocyte ratio (NLR) was analysed. Age (p < 0.05), relative LP-V15 (p = 0.037) and absolute PBM-mean (p < 0.001) were found to be negative related to NLR. Conclusion The dosimetric parameters of relative irradiated volume of BM have more statistically significant datas on acute HT than absolute irradiated volume. The nadir of haemoglobin and platelets and the vertice of NLR were more affected by the irradiation dose to LP, while neutrophils were more affected by the dose to IL. Acute HT was negative related to both low-dose irradiation (V10-30) and high-dose irradiation (V40, V50). For more than 4 cycles of CCT, the effect of BM irradiation on the neutrophils nadir was masked by chemotherapy.
first_indexed 2024-04-09T18:53:22Z
format Article
id doaj.art-f79ef718cf92431fa267f011d32a646b
institution Directory Open Access Journal
issn 1748-717X
language English
last_indexed 2024-04-09T18:53:22Z
publishDate 2023-04-01
publisher BMC
record_format Article
series Radiation Oncology
spelling doaj.art-f79ef718cf92431fa267f011d32a646b2023-04-09T11:23:18ZengBMCRadiation Oncology1748-717X2023-04-011811910.1186/s13014-023-02248-xThe impact of bone marrow irradiation dose on acute haematologic toxicity in cervical cancer patients treated with concurrent chemoradiotherapyMin Chen0Dajiang Wang1Zhirong Bao2Zongbi Yi3Zijie Mei4Shaoxing Sun5Qingming Xiang6Chunxu Yang7Hui Yang8Hui Qiu9Conghua Xie10Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan UniversityDepartment of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan UniversityDepartment of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan UniversityDepartment of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan UniversityDepartment of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan UniversityDepartment of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan UniversityDepartment of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan UniversityDepartment of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan UniversityDepartment of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan UniversityDepartment of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan UniversityDepartment of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan UniversityAbstract Objective To evaluate the impact of bone marrow (BM) irradiation dose on acute haematologic toxicity (HT) in concurrent chemoradiotherapy for cervical cancer. Methods Sixty-nine patients with cervical cancer treated with curative or postoperative adjuvant therapy received weekly cisplatin concurrent chemotherapy (CCT) and intensity-modulated radiation therapy (IMRT). The whole pelvic bone marrow (PBM) was delineated and divided into three subsites: ilium (IL), lower pelvis (LP), and lumbosacral spine (LS). Associations between clinical variables, dose volume of BM, including PBM, IL, LP, and LS in the form of x-Vy (volume receiving y Gy for x), and blood cell count nadir were tested using linear regression models. Receiver operating characteristic (ROC) curve analysis was further used to analyse the cutoff values of the variables with p < 0.05 in the multivariate analysis. Results In 69 patients, the haemoglobin nadir was positive correlated with baseline haemoglobin (p < 0.001), negative correlated with relative LP-V10 (p = 0.005), relative LP-V25 (p = 0.002), relative LP-V50 (p = 0.007), relative LP-mean (p = 0.003), absolute LP-V15 (p = 0.049), absolute LP-V25 (p = 0.004) and absolute LP-V30 (p = 0.009). The platelet nadir was positive correlated with baseline platelets (p = 0.048) and negative correlated with relative LP-V40 (p = 0.028), but there was no significant variable in absolute radiation volume by multivariate analysis. No variables related to the neutrophil nadir were found, and the 69 patients were divided into group A (43 cases) receiving 3–4 cycles of CCT and group B (26 cases) receiving 5–6 cycles of CCT. In group A, the relative IL-V15 (p = 0.014), the relative IL-V50 (p = 0.010) and the absolute LP-V50 (p = 0.011) were negative correlated with the neutrophil nadir. No significant variable was found in group B. No significant variables related to the lymphocyte nadir were found, and the neutrophil-to-lymphocyte ratio (NLR) was analysed. Age (p < 0.05), relative LP-V15 (p = 0.037) and absolute PBM-mean (p < 0.001) were found to be negative related to NLR. Conclusion The dosimetric parameters of relative irradiated volume of BM have more statistically significant datas on acute HT than absolute irradiated volume. The nadir of haemoglobin and platelets and the vertice of NLR were more affected by the irradiation dose to LP, while neutrophils were more affected by the dose to IL. Acute HT was negative related to both low-dose irradiation (V10-30) and high-dose irradiation (V40, V50). For more than 4 cycles of CCT, the effect of BM irradiation on the neutrophils nadir was masked by chemotherapy.https://doi.org/10.1186/s13014-023-02248-xDdosimetric parametersAcute haematologic toxicityCervical cancerConcurrent chemoradiotherapy
spellingShingle Min Chen
Dajiang Wang
Zhirong Bao
Zongbi Yi
Zijie Mei
Shaoxing Sun
Qingming Xiang
Chunxu Yang
Hui Yang
Hui Qiu
Conghua Xie
The impact of bone marrow irradiation dose on acute haematologic toxicity in cervical cancer patients treated with concurrent chemoradiotherapy
Radiation Oncology
Ddosimetric parameters
Acute haematologic toxicity
Cervical cancer
Concurrent chemoradiotherapy
title The impact of bone marrow irradiation dose on acute haematologic toxicity in cervical cancer patients treated with concurrent chemoradiotherapy
title_full The impact of bone marrow irradiation dose on acute haematologic toxicity in cervical cancer patients treated with concurrent chemoradiotherapy
title_fullStr The impact of bone marrow irradiation dose on acute haematologic toxicity in cervical cancer patients treated with concurrent chemoradiotherapy
title_full_unstemmed The impact of bone marrow irradiation dose on acute haematologic toxicity in cervical cancer patients treated with concurrent chemoradiotherapy
title_short The impact of bone marrow irradiation dose on acute haematologic toxicity in cervical cancer patients treated with concurrent chemoradiotherapy
title_sort impact of bone marrow irradiation dose on acute haematologic toxicity in cervical cancer patients treated with concurrent chemoradiotherapy
topic Ddosimetric parameters
Acute haematologic toxicity
Cervical cancer
Concurrent chemoradiotherapy
url https://doi.org/10.1186/s13014-023-02248-x
work_keys_str_mv AT minchen theimpactofbonemarrowirradiationdoseonacutehaematologictoxicityincervicalcancerpatientstreatedwithconcurrentchemoradiotherapy
AT dajiangwang theimpactofbonemarrowirradiationdoseonacutehaematologictoxicityincervicalcancerpatientstreatedwithconcurrentchemoradiotherapy
AT zhirongbao theimpactofbonemarrowirradiationdoseonacutehaematologictoxicityincervicalcancerpatientstreatedwithconcurrentchemoradiotherapy
AT zongbiyi theimpactofbonemarrowirradiationdoseonacutehaematologictoxicityincervicalcancerpatientstreatedwithconcurrentchemoradiotherapy
AT zijiemei theimpactofbonemarrowirradiationdoseonacutehaematologictoxicityincervicalcancerpatientstreatedwithconcurrentchemoradiotherapy
AT shaoxingsun theimpactofbonemarrowirradiationdoseonacutehaematologictoxicityincervicalcancerpatientstreatedwithconcurrentchemoradiotherapy
AT qingmingxiang theimpactofbonemarrowirradiationdoseonacutehaematologictoxicityincervicalcancerpatientstreatedwithconcurrentchemoradiotherapy
AT chunxuyang theimpactofbonemarrowirradiationdoseonacutehaematologictoxicityincervicalcancerpatientstreatedwithconcurrentchemoradiotherapy
AT huiyang theimpactofbonemarrowirradiationdoseonacutehaematologictoxicityincervicalcancerpatientstreatedwithconcurrentchemoradiotherapy
AT huiqiu theimpactofbonemarrowirradiationdoseonacutehaematologictoxicityincervicalcancerpatientstreatedwithconcurrentchemoradiotherapy
AT conghuaxie theimpactofbonemarrowirradiationdoseonacutehaematologictoxicityincervicalcancerpatientstreatedwithconcurrentchemoradiotherapy
AT minchen impactofbonemarrowirradiationdoseonacutehaematologictoxicityincervicalcancerpatientstreatedwithconcurrentchemoradiotherapy
AT dajiangwang impactofbonemarrowirradiationdoseonacutehaematologictoxicityincervicalcancerpatientstreatedwithconcurrentchemoradiotherapy
AT zhirongbao impactofbonemarrowirradiationdoseonacutehaematologictoxicityincervicalcancerpatientstreatedwithconcurrentchemoradiotherapy
AT zongbiyi impactofbonemarrowirradiationdoseonacutehaematologictoxicityincervicalcancerpatientstreatedwithconcurrentchemoradiotherapy
AT zijiemei impactofbonemarrowirradiationdoseonacutehaematologictoxicityincervicalcancerpatientstreatedwithconcurrentchemoradiotherapy
AT shaoxingsun impactofbonemarrowirradiationdoseonacutehaematologictoxicityincervicalcancerpatientstreatedwithconcurrentchemoradiotherapy
AT qingmingxiang impactofbonemarrowirradiationdoseonacutehaematologictoxicityincervicalcancerpatientstreatedwithconcurrentchemoradiotherapy
AT chunxuyang impactofbonemarrowirradiationdoseonacutehaematologictoxicityincervicalcancerpatientstreatedwithconcurrentchemoradiotherapy
AT huiyang impactofbonemarrowirradiationdoseonacutehaematologictoxicityincervicalcancerpatientstreatedwithconcurrentchemoradiotherapy
AT huiqiu impactofbonemarrowirradiationdoseonacutehaematologictoxicityincervicalcancerpatientstreatedwithconcurrentchemoradiotherapy
AT conghuaxie impactofbonemarrowirradiationdoseonacutehaematologictoxicityincervicalcancerpatientstreatedwithconcurrentchemoradiotherapy